BR0011498A - Cycloiminodepsipeptides and their use to combat endoparasites - Google Patents

Cycloiminodepsipeptides and their use to combat endoparasites

Info

Publication number
BR0011498A
BR0011498A BR0011498-7A BR0011498A BR0011498A BR 0011498 A BR0011498 A BR 0011498A BR 0011498 A BR0011498 A BR 0011498A BR 0011498 A BR0011498 A BR 0011498A
Authority
BR
Brazil
Prior art keywords
cycloiminodepsipeptides
endoparasites
combat
combat endoparasites
cycleiminodepsipeptides
Prior art date
Application number
BR0011498-7A
Other languages
Portuguese (pt)
Inventor
Peter Jeschke
Achim Harder
Georg Von Samson Himmelstjerna
Gerhard Bonse
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of BR0011498A publication Critical patent/BR0011498A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D273/00Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Patente de Invenção: "CICLOIMINODEPSIPEPTìDEOS E SEU EMPREGO PARA COMBATER ENDOPARASITAS". A presente invenção refere-se a cicloiminodepsipeptídeos da fórmula (1), especialmente cicloiminodepsípeptídeos com 24 membros, processos para a sua preparação e sua aplicação para combater endoparasitas.Invention Patent: "CYCLEIMINODEPSIPEPTIDES AND THEIR USE TO FIGHT ENDOPARASITES". The present invention relates to cycloiminodepsipeptides of the formula (1), especially 24-membered cycloiminodepsipeptides, processes for their preparation and their application to combat endoparasites.

BR0011498-7A 1999-06-11 2000-05-30 Cycloiminodepsipeptides and their use to combat endoparasites BR0011498A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19926620A DE19926620A1 (en) 1999-06-11 1999-06-11 New cycloiminodepsipeptides, processes for their preparation and their use in combating endoparasites
PCT/EP2000/004935 WO2000076985A1 (en) 1999-06-11 2000-05-30 Cyclo-imino depsipeptides and their utilization in controlling endoparasites

Publications (1)

Publication Number Publication Date
BR0011498A true BR0011498A (en) 2002-04-02

Family

ID=7910898

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0011498-7A BR0011498A (en) 1999-06-11 2000-05-30 Cycloiminodepsipeptides and their use to combat endoparasites

Country Status (11)

Country Link
EP (1) EP1192142A1 (en)
JP (1) JP2003502318A (en)
CN (1) CN1355794A (en)
AU (1) AU768501B2 (en)
BR (1) BR0011498A (en)
CA (1) CA2374632A1 (en)
DE (1) DE19926620A1 (en)
HK (1) HK1047589A1 (en)
HU (1) HUP0201592A2 (en)
WO (1) WO2000076985A1 (en)
ZA (1) ZA200109179B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4902519B2 (en) * 2007-12-21 2012-03-21 大塚化学株式会社 Immobilized catalyst
MX2021001566A (en) * 2015-05-20 2022-09-12 Boehringer Ingelheim Animal Health Usa Inc Anthelmintic depsipeptide compounds.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4317432A1 (en) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptides with endoparasiticidal activity
DE4317457A1 (en) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptides with endoparasiticidal activity
DE19713626A1 (en) * 1997-04-02 1998-10-08 Bayer Ag New thiodepsipeptides to control endoparasites and a simple process for their preparation

Also Published As

Publication number Publication date
CA2374632A1 (en) 2000-12-21
WO2000076985A1 (en) 2000-12-21
CN1355794A (en) 2002-06-26
ZA200109179B (en) 2003-01-29
AU768501B2 (en) 2003-12-11
HK1047589A1 (en) 2003-02-28
HUP0201592A2 (en) 2002-08-28
EP1192142A1 (en) 2002-04-03
AU5218000A (en) 2001-01-02
JP2003502318A (en) 2003-01-21
DE19926620A1 (en) 2000-12-14

Similar Documents

Publication Publication Date Title
SE0001899D0 (en) New compounds
BR0112589A (en) Heteroaryl derivatives and their application as a medicine
BR0112030A (en) New compounds that have antibacterial, antifungal or antitumor activity
DOP2002000429A (en) IMIDAZOTRIAZINAS
BR0214469A (en) 17alpha-alkyl-17beta-oxystratrienes and intermediate products for their preparation, application of 17alpha-alkyl-17beta-oxystratrienes for the preparation of medicaments as well as pharmaceutical preparations
BR0114410A (en) Combination of a cb1 receptor antagonist and sibutramine, the pharmaceutical compositions containing them and their use for the treatment of obesity
BR0214343A (en) 11 - Beta - Hydroxy Steroid Dehydrogenase Inhibitors Type 1
BR0108893A (en) Pharmaceutical composition, compound and compound preparation process
BR0115411A (en) Synergistic combinations comprising a renin inhibitor for cardiovascular diseases.
BR0213358A (en) Flibanserin use
WO2004067550A3 (en) Novel use of mifepristone and derivatives thereof as hedgehog protein signalling pathway modulators and applications of same
TR200200579T2 (en) Amino-thyrazolpyridine derivatives.
BR0112591A (en) Acridine derivatives and their application as a medicine
BR0210028A (en) Antibacterial agents
BR0013009A (en) Use of cgrp antagonists and cgrp release inhibitors to combat menopausal hot jets
BR0113590A (en) 7-oxopyridopyrimidines
SE0101932D0 (en) Pharmaceutical combinations
BRPI0406824A (en) Antibacterial indolonaoxazoldinones, intermediates for their preparation and pharmaceutical compositions containing them
BR0012291A (en) Fenoxifluorpirimidines
BR0009211A (en) Resorcinol derivatives
BR9812443A (en) 1-2-3-4-5-6-hexahydro-2,6-methane-3-benzazocin-10-ols substituted, processes for their preparation and use as medicines
PT1107793E (en) DEXTRANE-LEPTIN CONJUGATES, PHARMACEUTICAL COMPOSITIONS AND RELATED PROCESSES
ATE326451T1 (en) QUINAZOLINE DERIVATIVES AND THERAPEUTIC USES THEREOF
BR0011498A (en) Cycloiminodepsipeptides and their use to combat endoparasites
BR0009285A (en) Avermectin derivatives

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1927 DE 11/12/2007.